Mild generalised pustular psoriasis patient with a heterozygous hypomorphic MPO variant successfully treated with granulocyte and monocyte adsorption apheresis
Experimental Dermatology · 2023
DOI: 10.1111/exd.14846 ↗Kurz gefasst
Fallbericht in der Zeitschrift Experimental Dermatology, 2023. Verfasst von Takuya Takeichi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Skin Diseases, Vesiculobullous, Psoriasis, Blood Component Removal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Japan Science and Technology Agency, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Pathogenic variants in MPO , which encodes the myeloperoxidase, were reported as causative genetic defects in several cases of generalised pustular psoriasis (GPP) in addition to patients with myeloperoxidase deficiency in 2020. However, which clinical subtypes of GPP patients have pathogenic variants in MPO remains largely undetermined, and elucidating this is clinically important. The present report outlines a mild case of GPP with a rare missense heterozygous variant, c.1810C>T p.(Arg604Cys), in MPO . Our structural analysis and functional assays to measure myeloperoxidase activity suggest that the present MPO substitution is a hypomorphic variant in MPO . Thus, the mild phenotype of the present GPP patient might be associated with an incomplete hypomorphic loss‐of‐function variant in MPO . Additionally, the severe intractable edematous pustules and erythema improved dramatically after five rounds of granulocyte and monocyte adsorption apheresis (GMA) therapy. This is the first report of GMA treatment for GPP associated with a pathogenic variant in MPO , as far as we know. Our findings suggest that GMA might be a useful and powerful tool for controlling GPP in patients with myeloperoxidase deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Bioinformatics, Institute of Biochemistry, Biotechnology and Bioinformatics (IBBB), The Islamia University of Bahawalpur, Bahawalpur, Pakistan.
- Department of Bioinformatics & Biotechnology, Government College University Faisalabad, Faisalabad, Pakistan.
- Department of Dermatology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
- Department of Dermatology, Asahi University Hospital, Gifu, Japan.
ORCID-Profile: Takuya Takeichi
Förderung
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
Zitieren
APA
Takeichi, T., Yoshikawa, T., Iqbal, M. N., Farooq, M., Taki, T., Muro, Y., Shimomura, Y., Seishima, M., & Akiyama, M. (2023). Mild generalised pustular psoriasis patient with a heterozygous hypomorphic MPO variant successfully treated with granulocyte and monocyte adsorption apheresis. Experimental Dermatology. https://doi.org/10.1111/exd.14846
Vancouver
Takeichi T, Yoshikawa T, Iqbal MN, Farooq M, Taki T, Muro Y, et al. Mild generalised pustular psoriasis patient with a heterozygous hypomorphic MPO variant successfully treated with granulocyte and monocyte adsorption apheresis. Experimental Dermatology. 2023. doi:10.1111/exd.14846
BibTeX
@article{Takeichi2023,
author = {Takeichi, Takuya and Yoshikawa, Takenori and Iqbal, Muhammad Nasir and Farooq, Muhammad and Taki, Tomoki and Muro, Yoshinao and Shimomura, Yutaka and Seishima, Mariko and Akiyama, Masashi},
title = {Mild generalised pustular psoriasis patient with a heterozygous hypomorphic MPO variant successfully treated with granulocyte and monocyte adsorption apheresis},
journal = {Experimental Dermatology},
year = {2023},
doi = {10.1111/exd.14846}
}
EUVIMED